Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Long-Term Growth Stock May be About to Turn Bullish Again

At its all-time high of $194.77, made in June, Panera Bread Co (NASDAQ:PNRA) was up more than 20% year to date. But after some tough love from investors following its earnings announcement in July, the stock is now up only about 4% on the year.

In the past few years, PNRA has displayed stellar price action that the trend-following community has enjoyed immensely. And despite weakness during the second half of the summer, the stock remains above all important trendlines, and thus favors another rally in the medium term.

If PNRA can overcome its mid-September highs, it should present a potentially rewarding long-side setup with defined risk for traders to sink their teeth into.

Panera Bread Co (NASDAQ:PNRA)

To gain some perspective, let’s first take a look at the long-term chart going back to 2005. After an initial run in the 2005 through April 2006 period, this growth stock slipped into a three-and-a-half-year correction period and didn’t see any meaningful breakout until late 2009.

What stands out most about this period is the stock’s seeming disregard for the 2008-2009 financial crisis, at least as far as pure price action is concerned. While most stocks fell for 6-12 months, PNRA only sold off for about two months. This is emblematic of a growth stock and a very bullish sign.

PNRA ultimately broke through a multiyear resistance line in late 2009, sparking a relentless multiyear rally that so far saw its high in May of this year.

In the fashion in which only a growth stock turned cult stock can move, looking at the next chart we see PNRA rallied steeply from 2010 into its 2013 highs, all the while consolidating its rally phases with smaller mean-reversion moves toward the broader uptrend line. This type of healthy price action is why the stock appears capable of making higher highs in the coming months.

Moving on to the daily chart below, the first thing to note is the big one-day sell-off on July 23, following the company’s earnings announcement. The stock dropped 6.8% on the day, snapping its 200-day simple moving average (lower blue line).

Over ensuing weeks, PNRA did manage to recover roughly half of the post-earnings losses, but ultimately fell to a lower low in early September, an obvious sign that further price discovery at lower levels was necessary.

Since the early September lows, the stock has traded in a choppy fashion as it rallied into a resistance/confluence zone made up of its 200-day and 50-day simple moving averages. Typically, PNRA has respected those moving averages better at points where they coincided, which was once again the case last week as the stock’s post-FOMC rally got rejected at that point.

The price action following the July sell-off has not been bullish, but since betting against growth stocks holding their longer-term support lines isn’t my line of business, I am not looking to short PNRA at this juncture. Rather, a move back above the 200-day simple moving average and past last week’s high of $173.85 would be a visibly bullish signal and could get this stock back on track and making higher highs.

Recommended Trade Setup:

— Buy PNRA on a break above $173.85
— Set stop-loss at $168.50
— Set initial price target at $185 for a potential 6% gain in 8-12 weeks

Note: Learn more about the strategies Serge Berger uses to create profits in the market every day. Download his trading plan in the “Essence of Swing Trading” eBook by clicking here.

$1,000 Per Month Trading System

You could collect $1,000 or more per month without buying a single stock. Click here to learn how…

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!